Gilead Sciences Inc (GILD)

GILD (NASDAQ:Drugs) EQUITY
$85.14
pos +0.00
+0.00%
Today's Range: 84.45 - 88.02 | GILD Avg Daily Volume: 10,568,500
Last Update: 02/05/16 - 3:59 PM EST
Volume: 0
YTD Performance: -15.85%
Open: $0.00
Previous Close: $86.68
52 Week Range: $81.89 - $123.37
Oustanding Shares: 1,441,180,186
Market Cap: 124,921,498,522
6-Month Chart
TheStreet Ratings Grade for GILD
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 9 9 9 9
Moderate Buy 2 2 2 2
Hold 5 4 4 3
Moderate Sell 0 1 1 1
Strong Sell 0 0 0 0
Mean Rec. 1.75 1.81 1.81 1.73
Latest Dividend: 0.43
Latest Dividend Yield: 1.98%
Dividend Ex-Date: 03/14/16
Price Earnings Ratio: 6.87
Price Earnings Comparisons:
GILD Sector Avg. S&P 500
6.87 7.30 30.32
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-21.03% -14.77% 110.04%
GROWTH 12 Mo 3 Yr CAGR
Revenue 122.20 1.97 0.43
Net Income 0.00 3.32 0.62
EPS 0.00 3.39 0.63
Earnings for GILD:
EBITDA 16.32B
Revenue 0.00B
Average Earnings Estimates
Qtr (03/16) Qtr (06/16) FY (12/16) FY (12/17)
Average Estimate $2.82 $2.89 $11.49 $11.60
Number of Analysts 2 2 2 2
High Estimate $2.95 $2.98 $11.93 $12.25
Low Estimate $2.68 $2.81 $11.04 $10.95
Prior Year $2.89 $3.10 $12.45 $11.49
Growth Rate (Year over Year) -2.60% -6.61% -7.75% 1.00%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Bret Jensen

 | Feb 7, 2016 | 12:00 PM EST

They offer impressive free cash flow, great balance sheets, evolving pipelines and nice dividend yields.

By

Jim Cramer

 | Feb 3, 2016 | 6:16 AM EST

We have a flawed asset class that doesn't trade on anything but whim.

By

Bret Jensen

 | Feb 2, 2016 | 9:00 AM EST

In a year's time, investors may look back and think this was a great entry point.

By

Jim Cramer

 | Feb 1, 2016 | 11:07 AM EST

TheStreet's Jim Cramer talked about retail stocks Gap and Macy's on Monday from the floor of the New York Stock Exchange.

By

Jim Cramer

 | Feb 1, 2016 | 10:35 AM EST

Jim Cramer says healthcare companies will be in the spotlight this week and investors should take a long term view of the sector if the stocks selloff.

By

Tony Owusu

 | Feb 1, 2016 | 8:30 AM EST

Results from a tech, biotech and restaurant stock will be particularly important.

By

Tony Owusu

 | Jan 29, 2016 | 4:51 PM EST

Tech leads the way up while biotech lags behind.

By

Bruce Kamich

 | Jan 29, 2016 | 9:37 AM EST

Prices could find some support or buying interest at $80.

By

Bret Jensen

 | Jan 26, 2016 | 10:00 AM EST

Celgene, AbbVie and Gilead are set to report earnings. Here's what to look for.

By

Skip Raschke

 | Jan 26, 2016 | 8:30 AM EST

An ETF should be considered as a hedging candidate.

Flat as a pancake.
Thus far, Jim "El Capitan" Cramer doesnt yet get his wish.
...

We had expected a recovery in energy prices and better things from the stocks for some tim...
Industrials have seen their revenues and earnings outlook slow in the past year due to a s...
Get your cues from market legends like Jesse Livermore... http://realmoneypro.thestreet.co...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.